HEADER VIRAL PROTEIN 05-JUN-19 6RWG TITLE STRUCTURE OF HIV-1 CACSP1NC MUTANT(W41A,M42A) INTERACTING WITH TITLE 2 MATURATION INHIBITOR EP39 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG POLYPROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: EVERY MODEL HAS CHAIN A,B AND C. CHAIN A CONTAINS 157 COMPND 7 AMINO ACIDS. CHAIN B AND CHAIN C ARE ZINC ATOMS. 2 ZINC ATOMS BIND TO COMPND 8 NC AND FORM 2 ZINC FINGERS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: GAG; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GAG, HIV-1, MATURATION INHIBITOR, EP39, STRUCTURAL GENOMICS, PSI- KEYWDS 2 BIOLOGY, STRUCTURAL GENOMICS CONSORTIUM, SGC, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR X.CHEN,P.CORIC,V.LARUE,S.NONIN-LECOMTE,S.BOUAZIZ,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 4 19-JUN-24 6RWG 1 REMARK REVDAT 3 14-JUN-23 6RWG 1 REMARK REVDAT 2 09-SEP-20 6RWG 1 JRNL REVDAT 1 20-MAY-20 6RWG 0 JRNL AUTH X.CHEN,P.CORIC,V.LARUE,S.TURCAUD,X.WANG,S.NONIN-LECOMTE, JRNL AUTH 2 S.BOUAZIZ JRNL TITL THE HIV-1 MATURATION INHIBITOR, EP39, INTERFERES WITH THE JRNL TITL 2 DYNAMIC HELIX-COIL EQUILIBRIUM OF THE CA-SP1 JUNCTION OF JRNL TITL 3 GAG. JRNL REF EUR.J.MED.CHEM. V. 204 12634 2020 JRNL REFN ISSN 0223-5234 JRNL PMID 32717487 JRNL DOI 10.1016/J.EJMECH.2020.112634 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6RWG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1292101757. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 25 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 300 UM [U-15N] HIV-1 CACSP1NC, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D NOESY-HSQC; REMARK 210 3D TOCSY-HSQC; 3D HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.5 PL 7, CCPNMR REMARK 210 ANALYSIS 2.4.2, ARIA 2.3.2, TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 500 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 58.67 -140.64 REMARK 500 1 ILE A 10 29.11 33.27 REMARK 500 1 GLU A 32 38.44 -88.23 REMARK 500 1 GLN A 33 41.53 -84.01 REMARK 500 1 THR A 67 -73.22 -60.11 REMARK 500 1 LEU A 68 -54.64 -148.46 REMARK 500 1 VAL A 78 102.52 -57.42 REMARK 500 1 ASN A 119 -32.79 176.10 REMARK 500 1 ARG A 134 -74.10 -74.18 REMARK 500 1 LYS A 136 -30.52 73.42 REMARK 500 1 LYS A 143 -63.36 71.82 REMARK 500 1 HIS A 146 144.87 77.72 REMARK 500 1 ALA A 156 -65.21 -137.33 REMARK 500 2 ILE A 10 40.76 -66.64 REMARK 500 2 SER A 35 107.25 -50.47 REMARK 500 2 ALA A 66 106.06 68.23 REMARK 500 2 THR A 67 -72.06 -72.16 REMARK 500 2 LEU A 68 -63.87 -143.67 REMARK 500 2 PRO A 81 75.94 -67.38 REMARK 500 2 GLN A 111 -75.77 70.82 REMARK 500 2 ARG A 112 -173.92 175.51 REMARK 500 2 CYS A 117 99.33 -69.49 REMARK 500 2 ASN A 119 -39.12 -175.58 REMARK 500 2 LYS A 122 29.36 -174.35 REMARK 500 2 HIS A 125 -162.22 -105.53 REMARK 500 2 PRO A 133 105.63 -45.59 REMARK 500 2 LYS A 136 75.89 -104.68 REMARK 500 2 LYS A 143 -71.76 -155.37 REMARK 500 2 MET A 148 -54.71 68.26 REMARK 500 2 GLN A 155 38.31 -87.86 REMARK 500 3 TYR A 2 146.91 -171.62 REMARK 500 3 GLU A 32 43.81 -89.86 REMARK 500 3 PRO A 81 -151.94 -67.17 REMARK 500 3 LYS A 84 21.47 -71.51 REMARK 500 3 THR A 100 -65.15 -90.55 REMARK 500 3 ASN A 110 -75.47 -174.86 REMARK 500 3 GLN A 111 147.81 -177.85 REMARK 500 3 ASN A 119 -43.42 -177.54 REMARK 500 3 HIS A 125 -140.47 -108.25 REMARK 500 3 PRO A 133 86.42 -61.31 REMARK 500 3 LYS A 135 -87.23 66.60 REMARK 500 3 GLN A 147 48.10 -86.23 REMARK 500 3 MET A 148 -54.96 68.03 REMARK 500 3 ARG A 154 149.93 67.49 REMARK 500 3 GLN A 155 -64.91 72.38 REMARK 500 4 PRO A 4 39.24 -75.24 REMARK 500 4 ALA A 66 117.03 68.80 REMARK 500 4 THR A 67 -84.04 -73.45 REMARK 500 4 LEU A 68 -59.29 -132.13 REMARK 500 4 PRO A 98 36.24 -73.99 REMARK 500 REMARK 500 THIS ENTRY HAS 149 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 117 SG REMARK 620 2 CYS A 120 SG 110.7 REMARK 620 3 HIS A 125 ND1 110.7 108.9 REMARK 620 4 CYS A 130 SG 106.7 110.6 109.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 202 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 138 SG REMARK 620 2 CYS A 141 SG 108.8 REMARK 620 3 HIS A 146 ND1 111.5 109.0 REMARK 620 4 CYS A 151 SG 108.0 110.5 108.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34409 RELATED DB: BMRB REMARK 900 STRUCTURE OF HIV-1 CACSP1NC MUTANT(W41A,M42A) INTERACTING WITH REMARK 900 MATURATION INHIBITOR EP39 DBREF 6RWG A 1 157 UNP E7DAY8 E7DAY8_9HIV1 271 427 SEQADV 6RWG ALA A 41 UNP E7DAY8 TRP 311 ENGINEERED MUTATION SEQADV 6RWG ALA A 42 UNP E7DAY8 MET 312 ENGINEERED MUTATION SEQRES 1 A 157 MET TYR SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 A 157 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 A 157 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 A 157 ASN ALA ALA THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 A 157 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 A 157 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 A 157 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 A 157 MET SER GLN VAL THR ASN PRO ALA THR ILE MET ILE GLN SEQRES 9 A 157 LYS GLY ASN PHE ARG ASN GLN ARG LYS THR VAL LYS CYS SEQRES 10 A 157 PHE ASN CYS GLY LYS GLU GLY HIS ILE ALA LYS ASN CYS SEQRES 11 A 157 ARG ALA PRO ARG LYS LYS GLY CYS TRP LYS CYS GLY LYS SEQRES 12 A 157 GLU GLY HIS GLN MET LYS ASP CYS THR GLU ARG GLN ALA SEQRES 13 A 157 ASN HET ZN A 201 1 HET ZN A 202 1 HETNAM ZN ZINC ION FORMUL 2 ZN 2(ZN 2+) HELIX 1 AA1 THR A 5 ILE A 10 1 6 HELIX 2 AA2 PRO A 17 ARG A 30 1 14 HELIX 3 AA3 SER A 35 ASN A 50 1 16 HELIX 4 AA4 ASN A 52 GLY A 63 1 12 HELIX 5 AA5 PRO A 64 ALA A 66 5 3 HELIX 6 AA6 LEU A 68 CYS A 75 1 8 HELIX 7 AA7 HIS A 83 ASN A 97 1 15 HELIX 8 AA8 PRO A 98 ASN A 107 1 10 HELIX 9 AA9 ARG A 112 LYS A 116 5 5 HELIX 10 AB1 GLN A 147 CYS A 151 5 5 LINK SG CYS A 117 ZN ZN A 201 1555 1555 2.30 LINK SG CYS A 120 ZN ZN A 201 1555 1555 2.30 LINK ND1 HIS A 125 ZN ZN A 201 1555 1555 2.01 LINK SG CYS A 130 ZN ZN A 201 1555 1555 2.29 LINK SG CYS A 138 ZN ZN A 202 1555 1555 2.30 LINK SG CYS A 141 ZN ZN A 202 1555 1555 2.30 LINK ND1 HIS A 146 ZN ZN A 202 1555 1555 2.00 LINK SG CYS A 151 ZN ZN A 202 1555 1555 2.29 SITE 1 AC1 5 CYS A 117 ASN A 119 CYS A 120 HIS A 125 SITE 2 AC1 5 CYS A 130 SITE 1 AC2 4 CYS A 138 CYS A 141 HIS A 146 CYS A 151 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1